Sotwe logo Sotwe logo

Top Tweets for #ims23rf

Rfonsi1's profile image
Rafael Fonseca MD πŸ¦”πŸ‡ΊπŸ‡ΈπŸœπŸ‡²πŸ‡½ Verified account @Rfonsi1
MM-014 clinical trial of Daratumumab-Pd Phase 2 study. Results are encouraging given what we knew about APOLLO (PFS ~12 months) versus here 23 months. All patients had prior len (1-2 prior LOT). Remains a consideration post lenalidomide maintenance? #IMS23RF #mmsm @NBahlis
Rfonsi1's tweet photo. MM-014 clinical trial of Daratumumab-Pd Phase 2 study. Results are encouraging given what we knew about APOLLO (PFS ~12 months) versus here 23 months. All patients had prior len (1-2 prior LOT). Remains a consideration post lenalidomide maintenance? #IMS23RF #mmsm @NBahlis https://t.co/MmYRo6Bbfu
0
11
3
3
3K
Rfonsi1's profile image
Rafael Fonseca MD πŸ¦”πŸ‡ΊπŸ‡ΈπŸœπŸ‡²πŸ‡½ Verified account @Rfonsi1
Final results of the CARTITUDE-1 clinical trial @YiLinMDPhD . 97 patients were treated and had a median FU of 33.4 months. #IMS23RF #mmsm https://t.co/ZEi1y4I568
Rfonsi1's tweet photo. Final results of the CARTITUDE-1 clinical trial @YiLinMDPhD . 97 patients were treated and had a median FU of 33.4 months. #IMS23RF #mmsm https://t.co/ZEi1y4I568 https://t.co/WKlmYEN0YG
0
26
7
10
6K
Rfonsi1's profile image
Rafael Fonseca MD πŸ¦”πŸ‡ΊπŸ‡ΈπŸœπŸ‡²πŸ‡½ Verified account @Rfonsi1
German GMMG-CONCEPT (Isa-KRD) study shows high rates of MRD negativity after induction, and a good number are sustained. Longer term fU is needed but the results are promising. #IMS23RF #mmsm https://t.co/vBOGOoG0xw
Rfonsi1's tweet photo. German GMMG-CONCEPT (Isa-KRD) study shows high rates of MRD negativity after induction, and a good number are sustained. Longer term fU is needed but the results are promising. #IMS23RF #mmsm https://t.co/vBOGOoG0xw https://t.co/yVufVj7OXH
1
31
11
0
3K
Rfonsi1's profile image
Rafael Fonseca MD πŸ¦”πŸ‡ΊπŸ‡ΈπŸœπŸ‡²πŸ‡½ Verified account @Rfonsi1
The clinical development curse against venetoclax for t(11;14) MM - How CANOVA was reported and why it is still critical patients with the t(11;14) have access to Ven. #IMS23RF #mmsm 1/x
Rfonsi1's tweet photo. The clinical development curse against venetoclax for t(11;14) MM - How CANOVA was reported and why it is still critical patients with the t(11;14) have access to Ven. #IMS23RF #mmsm 1/x
9
122
46
55
60K
Rfonsi1's profile image
Rafael Fonseca MD πŸ¦”πŸ‡ΊπŸ‡ΈπŸœπŸ‡²πŸ‡½ Verified account @Rfonsi1
@fdezdelarrea gave a great presentation describing kinetics and profiling of CART in CARTITUDE-4. First steps in the correlative search for predictors. #IMS23RF #mmsm
Rfonsi1's tweet photo. @fdezdelarrea gave a great presentation describing kinetics and profiling of CART in CARTITUDE-4. First steps in the correlative search for predictors. #IMS23RF #mmsm https://t.co/1wBItv5Mrb
1
5
1
0
632
Rfonsi1's profile image
Rafael Fonseca MD πŸ¦”πŸ‡ΊπŸ‡ΈπŸœπŸ‡²πŸ‡½ Verified account @Rfonsi1
Plenary session at #IMS23RF #mmsm genomic profiling of CESAR. FISH & NGS done. Approximations to know who is at true risk of progression still need refinement and this this is of great interest. Note 50% have 1q and 5% 17p del. Most mutations subclonal
Rfonsi1's tweet photo. Plenary session at #IMS23RF #mmsm genomic profiling of CESAR. FISH & NGS done. Approximations to know who is at true risk of progression still need refinement and this this is of great interest. Note 50% have 1q and 5% 17p del. Most mutations subclonal https://t.co/utoNY2yJ6n
0
14
3
2
2K
Rfonsi1's profile image
Rafael Fonseca MD πŸ¦”πŸ‡ΊπŸ‡ΈπŸœπŸ‡²πŸ‡½ Verified account @Rfonsi1
#IMS23RF #mmsm
HadidiSamer's profile image
Samer Al Hadidi, MD,MS,FACP Verified account @HadidiSamer
#IMS23 #mmsm OPTIMISMM final analysis Median follow up 64.5 months No difference in OS in ITT PFS 2 was better
HadidiSamer's tweet photo. #IMS23 #mmsm OPTIMISMM final analysis Median follow up 64.5 months No difference in OS in ITT PFS 2 was better https://t.co/0Lyws5tRDo
0
7
0
0
2K
0
2
1
0
871
Rfonsi1's profile image
Rafael Fonseca MD πŸ¦”πŸ‡ΊπŸ‡ΈπŸœπŸ‡²πŸ‡½ Verified account @Rfonsi1
@FelipeProsper describing Epigenomics changes in myeloma. IRF2 as essential for MM survival (increased in MM). Target genes of IRF2 are unregulated- even in precursor states. Associated with shorter OS. #IMS23RF #mmsm
Rfonsi1's tweet photo. @FelipeProsper describing Epigenomics changes in myeloma. IRF2 as essential for MM survival (increased in MM). Target genes of IRF2 are unregulated- even in precursor states. Associated with shorter OS. #IMS23RF #mmsm https://t.co/y5vDUczTyl
0
4
1
0
306
Rfonsi1's profile image
Rafael Fonseca MD πŸ¦”πŸ‡ΊπŸ‡ΈπŸœπŸ‡²πŸ‡½ Verified account @Rfonsi1
Dr Mala Shanmugan talking about the importance of metabolomics as a therapeutic target and it’s link to: oxidative stress, Venetoclax sensitivity,and other metabolic substrates. #IMS23RF #mmsm
Rfonsi1's tweet photo. Dr Mala Shanmugan talking about the importance of metabolomics as a therapeutic target and it’s link to: oxidative stress, Venetoclax sensitivity,and other metabolic substrates. #IMS23RF #mmsm https://t.co/EtyTIo0Us3
0
8
1
1
1K
Rfonsi1's profile image
Rafael Fonseca MD πŸ¦”πŸ‡ΊπŸ‡ΈπŸœπŸ‡²πŸ‡½ Verified account @Rfonsi1
Dr. @IreneGhobrial describing her work on single cell analysis - bulk sequencing is reductionism while single cell describes heterogeneity. Can detect primary genetic changes, circulating cells, T cell diversity, T cell health and target integrity #IMS23RF #mmsm
Rfonsi1's tweet photo. Dr. @IreneGhobrial describing her work on single cell analysis - bulk sequencing is reductionism while single cell describes heterogeneity. Can detect primary genetic changes, circulating cells, T cell diversity, T cell health and target integrity #IMS23RF #mmsm https://t.co/4EuK4OQzwd
1
29
2
1
2K
Rfonsi1's profile image
Rafael Fonseca MD πŸ¦”πŸ‡ΊπŸ‡ΈπŸœπŸ‡²πŸ‡½ Verified account @Rfonsi1
Very interesting work being presented regarding the origin of myeloma cells. Could they be earlier B cells? Very courageous research to try to address- but I would still have to see more. Particularly given switch translocations in IgH MM #IMS23RF #mmsm
3
33
8
1
4K
Rfonsi1's profile image
Rafael Fonseca MD πŸ¦”πŸ‡ΊπŸ‡ΈπŸœπŸ‡²πŸ‡½ Verified account @Rfonsi1
Tracking the origins of myeloma. Assessing VAF in hyperdiploid patients. Pre and postgain deletions. Great work as always by @FrancescoMaura4 group. #IMS23RF #mmsm
1
8
2
0
1K
DrRameza's profile image
Ramiro @DrRameza
The auditorium for the #IMS23RF #mmsm.
0
3
0
0
57
Rfonsi1's profile image
Rafael Fonseca MD πŸ¦”πŸ‡ΊπŸ‡ΈπŸœπŸ‡²πŸ‡½ Verified account @Rfonsi1
@FaithEDavies1 reviewing evolutionary patterns in #IMS23RF #mmsm and precursor conditions.
Rfonsi1's tweet photo. @FaithEDavies1 reviewing evolutionary patterns in #IMS23RF #mmsm and precursor conditions. https://t.co/7FVba563st
0
3
0
0
129
Rfonsi1's profile image
Rafael Fonseca MD πŸ¦”πŸ‡ΊπŸ‡ΈπŸœπŸ‡²πŸ‡½ Verified account @Rfonsi1
The beautiful auditorium for the #IMS23RF #mmsm. The session on the myeloma cell of origin will now start.
Rfonsi1's tweet photo. The beautiful auditorium for the #IMS23RF #mmsm. The session on the myeloma cell of origin will now start. https://t.co/Cd3FsDbzsx
1
61
3
0
3K
Rfonsi1's profile image
Rafael Fonseca MD πŸ¦”πŸ‡ΊπŸ‡ΈπŸœπŸ‡²πŸ‡½ Verified account @Rfonsi1
Peter Campbell from the Wellcome Trust presenting on the fascinating topic of mutations in normal tissues (albeit a bit depressing). #IMS23RF #mmsm
Rfonsi1's tweet photo. Peter Campbell from the Wellcome Trust presenting on the fascinating topic of mutations in normal tissues (albeit a bit depressing). #IMS23RF #mmsm https://t.co/4RSkXvHnVI
0
18
3
0
1K
Rfonsi1's profile image
Rafael Fonseca MD πŸ¦”πŸ‡ΊπŸ‡ΈπŸœπŸ‡²πŸ‡½ Verified account @Rfonsi1
Starting! #IMS23RF #mmsm
Rfonsi1's tweet photo. Starting! #IMS23RF #mmsm https://t.co/ZqZBIOXnVj
3
60
8
1
4K

Last Seen Hashtags on Sotwe

ε₯³s
anxiouspanda
Seen from France
snapchat filter:videos()
Seen from United States
kuboph
Seen from United States
snapchat
Seen from France
NintendoDirectJP
Seen from United States
SecretstoHide
Seen from United States
anxiouspanda() +filter:native_video
Seen from United Kingdom
bokepindo
Seen from Indonesia
Ψ³ΩƒΨ³_Ω…Ψ­Ψ§Ψ±Ω…_عربي

Trends for you

1
Willie
Under 10K tweets
2
Artificial Intelligence
Under 10K tweets
3
Microsoft
Under 10K tweets
4
Cassidy Hutchinson
Under 10K tweets
5
Teamily AI 2.0
Under 10K tweets
6
Apologize
Under 10K tweets
7
Verizon
Under 10K tweets
8
Kaytron Allen
Under 10K tweets
9
THE ENEMY
Under 10K tweets
10
Congratulations Elon
Under 10K tweets

Most Popular Users

elonmusk's profile image
1
Elon Musk Verified account
@elonmusk
241.6M followers
barackobama's profile image
2
Barack Obama Verified account
@barackobama
118.9M followers
cristiano's profile image
3
Cristiano Ronaldo Verified account
@cristiano
114.6M followers
realdonaldtrump's profile image
4
Donald J. Trump Verified account
@realdonaldtrump
111.9M followers
narendramodi's profile image
5
Narendra Modi Verified account
@narendramodi
107.2M followers
rihanna's profile image
6
Rihanna Verified account
@rihanna
98.7M followers
nasa's profile image
7
NASA Verified account
@nasa
92.4M followers
justinbieber's profile image
8
Justin Bieber Verified account
@justinbieber
91.8M followers
katyperry's profile image
9
KATY PERRY Verified account
@katyperry
90.1M followers
taylorswift13's profile image
10
Taylor Swift Verified account
@taylorswift13
84M followers
ladygaga's profile image
11
Lady Gaga Verified account
@ladygaga
75.5M followers
imvkohli's profile image
12
Virat Kohli Verified account
@imvkohli
73.5M followers
kimkardashian's profile image
13
Kim Kardashian Verified account
@kimkardashian
70.9M followers
youtube's profile image
14
YouTube Verified account
@youtube
68.8M followers
neymarjr's profile image
15
Neymar Jr Verified account
@neymarjr
66.5M followers
billgates's profile image
16
Bill Gates Verified account
@billgates
65.2M followers
selenagomez's profile image
17
Selena Gomez Verified account
@selenagomez
63.1M followers
theellenshow's profile image
18
The Ellen Show
@theellenshow
62.2M followers
cnn's profile image
19
CNN Verified account
@cnn
61.8M followers
x's profile image
20
X Verified account
@x
60.7M followers